Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.56 |
| ▸ | CES1 | P23141 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.52 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.52 |
| ▸ | FEN1 | P39748 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALB | P02768 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL29035684 | 0.80 | CES2 (0.52) | CES2CES1ALDH1A1ALOX15PTPN1 | |
| SCHEMBL5180748 | 0.80 | CES2 (0.68) | CES2CES1ALDH1A1ALOX15PTPN1 | |
| SCHEMBL466255 | 0.77 | ALDH1A1 (0.50) | CES2CES1ALDH1A1ALOX15PTPN1 | |
| SCHEMBL15180841 | 0.76 | CES2 (0.77) | CES2CES1ALDH1A1ALOX15PTPN1 | |
| SCHEMBL6002438 | 0.76 | CES2 (0.77) | CES2CES1ALDH1A1ALOX15PTPN1 | |
| SCHEMBL970209 | 0.75 | CES2 (0.54) | CES2CES1ALDH1A1ALOX15PTPN1 | |
| SCHEMBL29362443 | 0.75 | CES2 (0.68) | CES2CES1ALDH1A1ALOX15PTPN1 | |
| SCHEMBL30968201 | 0.75 | CES2 (0.68) | CES2CES1ALDH1A1ALOX15PTPN1 | |
| SCHEMBL97828 | 0.75 | CES2 (0.68) | CES2CES1ALDH1A1ALOX15PTPN1 | |
| SCHEMBL31021561 | 0.75 | CA12 (0.42) | CES2CES1ALDH1A1GAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111117349-A | Catalyst ink, preparation method thereof, fuel cell and vehicle | 长城汽车股份有限公司 | 2020-05-08 | — | — | CN | disclosed |
| EP-2763221-B1 | CATALYTIC INK ADJUSTMENT METHOD | NISSAN MOTOR (JP) | 2016-12-07 | — | — | EP | disclosed |
| CN-103782430-B | The control method of catalyst ink | NISSAN MOTOR CO.,LTD. (JP) | 2016-05-25 | — | — | CN | disclosed |
| US-9331340-B2 | Catalytic ink preparation method | NISSAN MOTOR CO., LTD. (JP) | 2016-05-03 | — | — | US | disclosed |
| CN-103098275-B | Electrode for fuel cell and membrane electrode assembly | NISSAN MOTOR | 2015-04-22 | — | — | CN | disclosed |
| US-20140228200-A1 | CATALYTIC INK PREPARATION METHOD | NISSAN MOTOR CO., LTD. (JP) | 2014-08-14 | — | — | US | disclosed |
| EP-2763221-A1 | CATALYTIC INK ADJUSTMENT METHOD | Nissan Motor Co., Ltd (JP) | 2014-08-06 | — | — | EP | disclosed |
| CN-103782430-A | Catalytic ink adjustment method | NISSAN MOTOR | 2014-05-07 | — | — | CN | disclosed |
| US-20130280637-A1 | FUEL CELL ELECTRODE AND MEMBRANE ELECTRODE ASSEMBLY | NISSAN MOTOR CO., LTD. | 2013-10-24 | — | — | US | disclosed |
| EP-2626935-A1 | ELECTRODE FOR FUEL CELL AND MEMBRANE ELECTRODE ASSEMBLY | Nissan Motor Co., Ltd (JP) | 2013-08-14 | — | — | EP | disclosed |
| CN-103098275-A | Electrode for fuel cell and membrane electrode assembly | NISSAN MOTOR | 2013-05-08 | — | — | CN | disclosed |
| WO-2012103113-A1 | PYRAZINE AND IMIDAZOLIDINE DERIVATIVES AND THEIR USES TO TREAT HEPATITIS C | GILEAD PHARMASSET, LLC (US) | 2012-08-02 | — | — | WO | disclosed |
| US-20090092975-A1 | SELECTABLE MARKER | MOLOGIC LTD (GB) | 2009-04-09 | — | — | US | disclosed |
| US-7050684-B2 | Composition comprising fluorinated, radiation-curable dyes for surface energy control | ALCATEL (FR) | 2006-05-23 | — | — | US | disclosed |
| EP-1375527-B1 | Composition comprising flourinated, radiation-curable dyes for surface energy control | DRAKA COMTEQ BV (NL) | 2005-12-14 | — | — | EP | disclosed |
| US-20050154078-A1 | Composition comprising fluorinated, radiation-curable dyes for surface energy control | ALCATEL | 2005-07-14 | — | — | US | disclosed |
| US-6844373-B2 | Composition comprising fluorinated, radiation-curable dyes for surface energy control | ALCATEL (FR) | 2005-01-18 | — | — | US | disclosed |
| EP-1375527-A2 | Composition comprising flourinated, radiation-curable dyes for surface energy control | ALCATEL (FR) | 2004-01-02 | — | — | EP | disclosed |
| US-20030225178-A1 | Composition comprising fluorinated, radiation-curable dyes for surface energy control | ALCATEL | 2003-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090092975-A1 | SELECTABLE MARKER | AMD1, PADI1, PSAT1 | CES2 849/4885CES1 75/4885ALDH1A1 46/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.